Researchers and clinical trials

“The reporting of harm is as important as the reporting of efficacy in publications of clinical trials,” a group of French researchers wrote in a study being published in Tuesday’s edition of Archives of Internal Medicine. “However, harm is frequently insufficiently reported.” How insufficiently?

more


This entry was posted in Biomedical research ethics.

Comments are closed.